FAFGX | LGRCX | FAFGX / LGRCX | |
Total Expense Ratio | 0.40 | 1.66 | 24% |
Annual Report Gross Expense Ratio | 0.40 | 1.67 | 24% |
Fund Existence | 5 years | 22 years | - |
Gain YTD | 13.309 | 8.901 | 150% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2500 | 10% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 330B | 17.5B | 1,886% |
Annual Yield % from dividends | 0.52 | 0.00 | - |
Returns for 1 year | 12.69 | 13.59 | 93% |
Returns for 3 years | 46.91 | 38.10 | 123% |
Returns for 5 years | N/A | 26.77 | - |
Returns for 10 years | N/A | 150.43 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EWQ | 43.82 | 0.27 | +0.62% |
iShares MSCI France ETF | |||
INTF | 35.49 | -0.01 | -0.03% |
iShares International Equity Factor ETF | |||
ZDEK | 24.88 | -0.05 | -0.21% |
Innovator Equity Defined Prt ETF -1YrDec | |||
EPHE | 26.25 | -0.09 | -0.34% |
iShares MSCI Philippines ETF | |||
BBC | 22.08 | -0.70 | -3.09% |
Virtus LifeSci Biotech Clinical Trls ETF |